4//SEC Filing
Forest Laboratories, LLC 4
Accession 0001209191-14-046076
CIK 0000038074operating
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:14 PM ET
Size
15.3 KB
Accession
0001209191-14-046076
Insider Transaction Report
Form 4
COUGHLIN CHRISTOPHER J
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2014-07-01−7,815→ 0 totalExercise: $34.54Exp: 2022-08-22→ Common Stock (7,815 underlying) - Disposition to Issuer
Common Stock
2014-07-01−1,527→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2014-07-01−20,000→ 0 totalExercise: $33.43Exp: 2021-08-22→ Common Stock (20,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-07-01−5,909→ 0 totalExercise: $42.61Exp: 2023-08-14→ Common Stock (5,909 underlying) - Disposition to Issuer
Restricted Stock
2014-07-01−2,406→ 0 total
Footnotes (5)
- [F1]Each share of common stock was disposed of pursuant to the Merger Agreement, dated as of February 17, 2014 (the "Merger Agreement"), by and among the issuer and Actavis plc ("Actavis"), Tango US Holdings Inc., Tango Merger Sub 1 LLC, and Tango Merger Sub 2 LLC in exchange for either (A) $26.04 in cash plus 0.3306 Actavis ordinary shares having a market value of $224 per share on the effective date of the merger or (B) $25.67 in cash plus 0.332623 Actavis ordinary shares having a market value of $224 per share on the effective date of the merger, depending on the consideration election made by the reporting person and the consideration election proration procedures set forth in the Merger Agreement.
- [F2]Outstanding restricted stock awards were assumed by Actavis pursuant to the Merger Agreement and replaced with an Actavis restricted stock unit award covering 0.4723 Actavis ordinary shares having a market value of $224 per share on the effective date of the merger for each issuer share underlying the restricted stock award.
- [F3]The options, 15,000 of which are currently exercisable and 5,000 of which vest on August 23, 2014, were assumed by Actavis pursuant to the Merger Agreement and replaced with an option to purchase a number of whole Actavis ordinary shares equal to the product of (i) the number of shares of issuer common stock subject to such issuer option multiplied by (ii) 0.4723, at an exercise price per share equal to the quotient obtained by dividing (x) the exercise price per share of the issuer option by (y) 0.4723.
- [F4]The options, which are currently exercisable, were assumed by Actavis pursuant to the Merger Agreement and replaced with an option to purchase a number of whole Actavis ordinary shares equal to the product of (i) the number of shares of issuer common stock subject to such issuer option multiplied by (ii) 0.4723, at an exercise price per share equal to the quotient obtained by dividing (x) the exercise price per share of the issuer option by (y) 0.4723.
- [F5]The options, which are currently exercisable, were assumed by Actavis pursuant to the Merger Agreement and replaced with an option to purchase a number of whole Actavis ordinary shares equal to the product of (i) the number of shares of issuer common stock subject to such issuer option multiplied by (ii) 0.4723, at an exercise price per share equal to the quotient obtained by dividing (x) the exercise price per share of the issuer option by (y) 0.4723.
Documents
Issuer
Forest Laboratories, LLC
CIK 0000038074
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000038074
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 5:14 PM ET
- Size
- 15.3 KB